Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer  Vinita Singh-Gupta, PhD, Michael.

Slides:



Advertisements
Similar presentations
E2 GSCE2 bulkG7 GSCG7 bulk Mean SF4Gy (95% CI) 0.78 (0.72, 0.83) 0.56 (0.47, 0.64) 0.65 (0.57,0.72) 0.43 (0.34,0.51) T test of meansp = 0.001p =
Advertisements

Glucocorticoids Augment the Chemically Induced Production and Gene Expression of Interleukin-1α through NF-κB and AP-1 Activation in Murine Epidermal.
Integrin-Linked Kinase Inhibitor KP-392 Demonstrates Clinical Benefitsin an Orthotopic Human Non-small Cell Lung Cancer Model  Jiang Liu, MD, Penny C.
Marcello Arsura, Min Wu, Gail E Sonenshein  Immunity 
Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1α Cell Physiol Biochem 2014;33:37-51.
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Yunguang Sun, PhD, Luigi Moretti, MD, Nicholas J
Radioprotection of Lung Tissue by Soy Isoflavones
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.
A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer  Steven.
Volume 133, Issue 5, Pages (November 2007)
The impact of the IGF-1 system of cancer cells on radiation response – An in vitro study  Senthiladipan Venkatachalam, Esther Mettler, Christian Fottner,
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis  Motofumi.
Resistance to EGFR-TKI Can Be Mediated through Multiple Signaling Pathways Converging upon Cap-Dependent Translation in EGFR-Wild Type NSCLC  Manish R.
Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation  Rosa M. Ten, MD, PhDa,
Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide  Bin Li, M.S., Ming.
Volume 69, Issue 4, Pages (February 2006)
Functional Investigation of Fas Ligand Expressions in Human Non-Small Cell Lung Cancer Cells and Its Clinical Implications  Yidan Lin, MD, PhD, Lunxu.
Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation 
Volume 133, Issue 6, Pages (December 2007)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,
The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death  Kwang Woon Kim, PhD, Christina K. Speirs,
A Histone Deacetylase Inhibitor LBH589 Downregulates XIAP in Mesothelioma Cell Lines Which is Likely Responsible for Increased Apoptosis With TRAIL  James.
MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity 
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils  Lisa M. Abernathy,
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
DNAPKcs is required for DNA repair in the presence of androgen.
Volume 68, Issue 3, Pages (September 2005)
Integrin-Linked Kinase Inhibitor KP-392 Demonstrates Clinical Benefitsin an Orthotopic Human Non-small Cell Lung Cancer Model  Jiang Liu, MD, Penny C.
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.
Volume 68, Issue 1, Pages (July 2005)
Jennifer L. Rizzo, Jessica Dunn, Adam Rees, Thomas M. Rünger 
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer  Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells  Sebastian Kobold,
Volume 13, Issue 8, Pages (November 2015)
The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin  Anjaiah Srirangam, PhD,
Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice  Jörg.
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression  Toran Sanli,
Terameprocol (Tetra-O-Methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-Mediated Survivin Transcription, Induces Radiosensitization in Non-small.
BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non- small Cell Lung Carcinoma In Vitro  Wenyan Li, MD, PhD, Bo Li, MD,
Enhanced Death Ligand-Induced Apoptosis in Cutaneous SCC Cells by Treatment with Diclofenac/Hyaluronic Acid Correlates with Downregulation of c-FLIP 
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and.
Franziska Hauth, Mahmoud Toulany, Daniel Zips, Apostolos Menegakis 
Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms  Markus Meissner, Andreas Pinter,
Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus  B. Krishnadasan, MD, B. Naidu, MBBS,
Volume 66, Issue 4, Pages e5 (May 2017)
Tatsushi Toyooka, Mio Ishihama, Yuko Ibuki 
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Volume 25, Issue 21, Pages (November 2015)
Testosterone dependent androgen receptor stabilization and activation of cell proliferation in primary human myometrial microvascular endothelial cells 
Schedule-Dependent Interaction between the Proteosome Inhibitor Bortezomib and the EGFR-TK Inhibitor Erlotinib in Human Non-small Cell Lung Cancer Cell.
Resistance of Human Melanoma Cells Against the Death Ligand TRAIL Is Reversed by Ultraviolet-B Radiation via Downregulation of FLIP  Elke Zeise, Michael.
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Single-Stranded DNA Orchestrates an ATM-to-ATR Switch at DNA Breaks
Volume 22, Issue 11, Pages (November 2015)
Davina A. Lewis, Dan F. Spandau  Journal of Investigative Dermatology 
Marcello Arsura, Min Wu, Gail E Sonenshein  Immunity 
Dimethylfumarate Specifically Inhibits the Mitogen and Stress-Activated Kinases 1 and 2 (MSK1/2): Possible Role for its Anti-Psoriatic Effect  Borbala.
Volume 119, Issue 5, Pages (November 2000)
1α,25-Dihydroxyvitamin D3 Stimulates Activator Protein 1 DNA-Binding Activity by a Phosphatidylinositol 3-Kinase/Ras/MEK/Extracellular Signal Regulated.
John W. Haycock, Mark Wagner, Sheila Mac Neil 
Volume 61, Issue 6, Pages (June 2002)
Volume 2, Issue 4, Pages (October 2002)
Deon G. Uffort, Elizabeth A. Grimm, Julie A. Ellerhorst 
Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Induces Vascular Permeability Factor (VPF/VEGF) Expression by Cultured Keratinocytes  Jens Gille, Mona.
Single-Stranded DNA Orchestrates an ATM-to-ATR Switch at DNA Breaks
Presentation transcript:

Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer  Vinita Singh-Gupta, PhD, Michael C. Joiner, PhD, Lindsay Runyan, BSc, Christopher K. Yunker, BSc, Fazlul H. Sarkar, PhD, Steven Miller, MD, Shirish M. Gadgeel, MD, Andre A. Konski, MD, Gilda G. Hillman, PhD  Journal of Thoracic Oncology  Volume 6, Issue 4, Pages 688-698 (April 2011) DOI: 10.1097/JTO.0b013e31821034ae Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 A549 cell growth inhibition by soy isoflavones and radiation. A, Soy dose titration. Cells were treated for 4 days with soy at concentration of 0, 10, 25, 50, 75, and 100 μM, and viable cells were counted. B, Radiation dose titration. Cells were irradiated with doses of 1, 2, 3, 5, 6, and 8 Gy, and viable cells were counted. Bars represent the mean number of cells of duplicate wells calculated as the percentage of control cells ± SE. *p < 0.001 relative to control group. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Survival fraction of A549 cells treated with soy and/or radiation. A, Survival of cells treated with soy. A549 cells were treated for 72 hours with soy at concentrations of 5, 7.5, 10, 15, 20, 25, and 30 μM and plated in a clonogenic assay. B, Survival of cells treated with radiation. A549 cells were irradiated with different doses of 1 to 10 Gy and plated in a clonogenic assay. Inset: the radiation dose survival curve is fitted by a nonlinear least-square regression according to the linear-quadratic formula (SAS JMPV7). C, Survival of cells treated with soy and radiation. A549 cells were pretreated with soy at 5, 7.5, and 10 μM for 72 hours, then irradiated at 3 Gy and plated in a clonogenic assay in the presence of the same concentration of soy. Inset in (C) shows the products of SF(S) and SF(R), which are the survival fraction of soy treatment at 5, 7.5, and 10 μM multiplied by the survival fraction of 3 Gy radiation SF(R). These products are greater than the survival fraction of cells treated with combined soy and radiation [SF(S + R)] at each concentration of soy tested. In panels A, B, and C, bars represent the mean survival fraction of triplicate wells ± SE. *p < 0.001 represent significance of each treatment group relative to control group. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Increased DNA double-strand breaks in A549 cells treated with soy and radiation. A549 cells were treated with soy at 30 μM for 24 hours then irradiated with 3 Gy and tested at 1 hour and 24 hours after radiation, corresponding to 24 and 48 hours of soy treatment, respectively. Control cells (con), cells treated with soy (soy), cells treated with radiation (Rad), and both combined (Soy + Rad) were processed for immunostaining of γ-H2AX to detect DNA double-strand breaks (DSBs). A, γ-H2AX staining at 1 hour after radiation or 24 hours after soy treatment. B, γ-H2AX staining at 24 hours after radiation or 48 hours after soy treatment. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Effect of soy and radiation on HIF-1α and γ-H2AX in A549 cells. Cells were either untreated (Con for control) or pretreated with 30 μM soy, 3 Gy radiation (Rad), or combined (Soy + Rad). Cells were pretreated with soy for 24 hours, and then cells were irradiated. At 1 hour or 24 hours post radiation, corresponding to 24 and 48 hours soy treatment, cells were processed for Western blot analysis to detect γ-H2AX and HIF-1α. β-Actin protein levels served as a loading control. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 5 Pretreatment with soy inhibits APE-1/Ref-1 expression and HIF-1α and NF-κB DNA-binding activity induced by radiation. A549 cells were pretreated with 30 μM soy for 72 hours then irradiated at 3 Gy. At 5 hours after radiation, nuclear extracts were subjected to Western blot analysis or electrophoretic mobility shift assay (EMSA). Untreated control (Con), soy alone (Soy), radiation 3 Gy (Rad), and soy combined with radiation (Soy + Rad). A, Nuclear expression of APE1/Ref-1. Nuclear extracts (10 μg) were run on 10% Western gel and blotted against APE-1/Ref-1 Ab. B, HIF-1α DNA-binding activity. Nuclear extracts were incubated with IRDye-700-labeled HIF-1α oligonucleotide and subjected to EMSA. C, NF-κB DNA-binding activity. Nuclear extracts were incubated with IRDye-700-labeled NF-κB oligonucleotide and subjected to EMSA. In panels A, B, and C, data are also presented as the mean integrated density value (I.D.V.) of the band/μg protein loaded (±SE). *p < 0.05 and ** p <0.001 represent significance of each treatment group relative to control group. Dotted lines and p values in I.D.V. diagrams show the difference between cells treated with radiation + soy versus radiation only. Western blot for retinoblastoma (Rb) protein in the nuclear extract was performed as an internal loading control. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 6 Effect of APE1/Ref-1 inhibitors on γ-H2AX expression in A549 cells. A549 cells were pretreated with E3330 (50 μM), methoxyamine (20 mM), or soy isoflavones (30 μM) for 24 hours and then irradiated at 3 Gy. Cells were further incubated for 1 hour and 24 hours after radiation and then processed for γ-H2AX immunostaining. Control cells (Control), cells treated with radiation (Rad) and both combined (Soy + Rad), and cells treated with E3330 and radiation (E3330 + Rad) or methoxyamine and radiation (Methox + Rad) were processed for immunostaining of γ-H2AX to detect DNA double-strand breaks (DSBs). A, Mean number of γ-H2AX foci per cell. B, Mean percent of γ-H2AX-positive cells per field. In both (A) and (B) panels, bars represent the mean values ± SD calculated from three different fields. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 7 Effect of APE1/Ref-1 inhibitors on A549 cell growth. A549 cells were pretreated either with E3330 (25 μM) or methoxyamine (10 mM), or soy isoflavones (15 μM) or in combination (E3330 + soy or Methox + soy) for 24 hours and then irradiated with 3 Gy. Cells were further incubated, and viable cells were counted at 3 days after radiation. Single treatment and combined treatments of E3330, methoxyamine, and soy isoflavones are also shown. Bars represent the mean number of cells of duplicate wells calculated as the percentage of control cells ± SE. Dotted lines and p values show the difference between cells treated with single and combined treatments; *p < 0.05 and **p < 0.005. Journal of Thoracic Oncology 2011 6, 688-698DOI: (10.1097/JTO.0b013e31821034ae) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions